Dr Serpell is Set to Embark on a New Academic Journey with UCL School of Pharmacy
The SISC Group at the University of Kent bids a fond farewell to Dr Chris Serpell as he embarks on an exciting new chapter at the UCL School of Pharmacy as an Associate Professor of Drug Discovery.
Dr Serpell’s illustrious academic journey began with a DPhil in Inorganic Chemistry at the University of Oxford under the mentorship of Prof Paul Beer. His passion for research and commitment to scientific innovation led him to postdoctoral fellowships at McGill University with Prof Hanadi Sleiman and later at Oxford with Prof Ben Davis FRS. In 2015, Dr Serpell joined the University of Kent, where he was subsequently appointed Senior Lecturer in 2018 and Reader in 2020, marking significant milestones in his career.
During his tenure at Kent, Dr Serpell’s research has made substantial contributions to the fields of supramolecular and macromolecular chemistry, particularly in biological structures and medicinal applications. His work on chemically modified nucleic acids, phosphoestamers, and the chemical biology of natural products from Southeast Asia has not only advanced our understanding of these areas but also paved the way for future innovations in drug discovery and development.
As Dr Serpell transitions to the UCL School of Pharmacy, his departure is felt deeply within the SISC community. However, his legacy of academic excellence, collaborative spirit, and pioneering research will continue to inspire and influence. We look forward to the potential for future collaborations and are excited to see the new heights Dr Serpell will reach in his research and academic endeavours at UCL.
Please join us in congratulating Dr Chris Serpell on his new appointment and wishing him all the success as he continues to push the boundaries of chemistry and make significant contributions to the scientific community. His journey is a testament to the enduring impact of dedication, innovation, and scholarly pursuit.